BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15189934)

  • 1. Treatment costs of community-acquired pneumonia in an employed population.
    Colice GL; Morley MA; Asche C; Birnbaum HG
    Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
    Sato R; Gomez Rey G; Nelson S; Pinsky B
    Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
    Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
    BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
    Cupurdija V; Lazic Z; Petrovic M; Mojsilovic S; Cekerevac I; Rancic N; Jakovljevic M
    J Bras Pneumol; 2015; 41(1):48-57. PubMed ID: 25750674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of treating community-acquired pneumonia.
    Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
    Clin Ther; 1998; 20(4):820-37. PubMed ID: 9737840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
    Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
    Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.
    McLaughlin JM; Johnson MH; Kagan SA; Baer SL
    Infection; 2015 Dec; 43(6):671-80. PubMed ID: 25980561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
    Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
    Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
    Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
    Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Private costs of patients hospitalized with community-acquired pneumonia.
    Jacobs P; Marrie TJ; Calder P
    Can Respir J; 2005; 12(4):205-8. PubMed ID: 16003457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.
    Schmedt N; Heuer OD; Häckl D; Sato R; Theilacker C
    BMC Health Serv Res; 2019 Jan; 19(1):30. PubMed ID: 30642312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
    Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
    Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA.
    Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
    J Comp Eff Res; 2020 Jan; 9(2):127-140. PubMed ID: 31840552
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospitalization costs of adult community-acquired pneumonia in England.
    Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
    J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with hospitalization costs for patients with community-acquired pneumonia.
    Merchant S; Mullins CD; Shih YC
    Clin Ther; 2003 Feb; 25(2):593-610. PubMed ID: 12749516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.
    Tan KK; Dang DA; Kim KH; Kartasasmita C; Kim HM; Zhang XH; Shafi F; Yu TW; Ledesma E; Meyer N
    Hum Vaccin Immunother; 2018 Jan; 14(1):95-105. PubMed ID: 29125809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.
    Yu H; Rubin J; Dunning S; Li S; Sato R
    J Am Geriatr Soc; 2012 Nov; 60(11):2137-43. PubMed ID: 23110409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
    Hoe LK; Keang LT
    Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
    Goss CH; Rubenfeld GD; Park DR; Sherbin VL; Goodman MS; Root RK
    Chest; 2003 Dec; 124(6):2148-55. PubMed ID: 14665494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.